Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases. This is ...
Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...
More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
New data from the American Cancer Society reveals an alarming trend: younger women are increasingly being diagnosed with breast cancer, prompting calls for earlier screenings.
The ECSU women's basketball team will play a home game against UMass Boston on Saturday at 3 p.m. to raise money for breast ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...